Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 125
Item hits:
Issue DateTitleAuthor(s)
1-Jan-2014Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse eventsCostabel, U; Bendstrup, E; Cottin, V; Dewint, P; Egan, JJJ, et al
15-Oct-2016Reply: Daily Home Spirometry: A New Milestone in the Field of Pulmonary FibrosisRussell, AM; Maher, TM; All authors; National Institute for Health Research
1-Jul-2018The burden of illness of idiopathic pulmonary fibrosis: a comprehensive evidence reviewDiamantopoulos, A; Wright, E; Vlahopoulou, K; Cornic, L; Schoof, N, et al
20-Aug-2018Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trialMaher, TM; Stowasser, S; Nishioka, Y; White, ES; Cottin, V, et al
15-Apr-2018Identification of diagnostic criteria for chronic hypersensitivity pneumonitis: an international modified Delphi surveyMorisset, J; Johannson, KA; Jones, KD; Wolters, PJ; Collard, HR, et al
4-Jul-2017Cough in fibrotic lung disease: An unresolved challenge.Saunders, P; Maher, TM
6-Oct-2017Combination therapy and the start of a new epoch for idiopathic pulmonary fibrosis?Maher, TM
1-Jun-2018Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysemaJacob, J; Bartholmai, BJ; Rajagopalan, S; Karwoski, R; Nair, A, et al
15-Jul-2018Rapidly progressive cystic lung diseaseRogers, C; Kent-Bramer, J; Devaraj, A; Nicholson, AG; Molyneaux, PL, et al
12-Apr-2017Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis who received pirfenidoneKreuter, M; Spagnolo, P; Wuyts, W; Renzoni, E; Koschel, D, et al